Literature DB >> 32038837

Establishment of a Stable Cell Line Expressing Green Fluorescence Protein-fused Hypoxia Inducible Factor-1α for Assessment of Carcinogenicity of Chemical Toxicants.

Sung-Hye Kim1,2, Hee-Won Seo1,2, Min-Ho Lee1,2, Jin-Ho Chung1, Byung Hoon Lee1, Mi-Ock Lee1,2.   

Abstract

Hypoxia inducible factor 1α (HIF-1α) is a potential marker of carcicnogenesis since it is overexpresssed in many human cancers such as brain, breast, and uterus, and its role has implicated in tumor cell growth and metastasis. In this study, we established a stable cell line that express green fluorescence protein (GFP)-fused hypoxia inducible factor 1α (HIF-1α) and evaluated the potential use of this cell line for assessment of carcinogenicity of chemical toxicants. Western blot analysis as well as fluorescence measurements showed that protein-level of GFP-HIF-1α was significantly enhanced in a dose-dependent manner upon treatment of hypoxia mimicking agents such as dexferrioxamine and CoCl2. Well-Known tumor promoters such as mitomycin and methyl methane-sulfonate. significantly induced the fluorescence intensity of GFP-HIF-1α, whereas the known negative controls such as o-anthranilic acid and benzethonium chloride, did not. These results indicate that HIF-1α could be a biological parameter for detection of tumor initiators/promoters and suggest that the GFP-HIF-1α cell line is a useful system for screening of carcinogenic toxicants. © Korean Society of Toxicology 2009.

Entities:  

Keywords:  Carcinogenicity; Chemical toxicants; GFP-HIF-1α stable cell line

Year:  2009        PMID: 32038837      PMCID: PMC7006318          DOI: 10.5487/TR.2009.25.4.189

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  31 in total

1.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.

Authors:  P C Mahon; K Hirota; G L Semenza
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 2.  Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks.

Authors:  Michael D Wyatt; Douglas L Pittman
Journal:  Chem Res Toxicol       Date:  2006-12       Impact factor: 3.739

Review 3.  Commentary: is the concept of "tumor promotion" a useful paradigm?

Authors:  J E Trosko
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

4.  Saturation toxicokinetics of thioacetamide: role in initiation of liver injury.

Authors:  Jaya Chilakapati; Kartik Shankar; Midhun C Korrapati; Ronald A Hill; Harihara M Mehendale
Journal:  Drug Metab Dispos       Date:  2005-09-23       Impact factor: 3.922

5.  The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro.

Authors:  M Tomasz; C M Mercado; J Olson; N Chatterjie
Journal:  Biochemistry       Date:  1974-11-19       Impact factor: 3.162

6.  The inhibitory effect of griseofulvin on the "promotion" of skin carcinogenesis.

Authors:  S D Vesselinovitch; N Mihailovich
Journal:  Cancer Res       Date:  1968-12       Impact factor: 12.701

7.  Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays.

Authors:  R W Tennant; B H Margolin; M D Shelby; E Zeiger; J K Haseman; J Spalding; W Caspary; M Resnick; S Stasiewicz; B Anderson
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

8.  Application of a two-stage Syrian hamster embryo cell transformation assay to cigarette smoke particulate matter.

Authors:  Damien Breheny; Haizhou Zhang; Eian D Massey
Journal:  Mutat Res       Date:  2005-05-02       Impact factor: 2.433

Review 9.  Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review.

Authors:  Michael C Humble; Carol S Trempus; Judson W Spalding; Ronald E Cannon; Raymond W Tennant
Journal:  Oncogene       Date:  2005-12-15       Impact factor: 9.867

Review 10.  Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.

Authors:  Ji-Won Lee; Seong-Hui Bae; Joo-Won Jeong; Se-Hee Kim; Kyu-Won Kim
Journal:  Exp Mol Med       Date:  2004-02-29       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.